Sun Pharma Q4 profit down 19% at Rs 2,149.8 cr, revenue up 8%
India’s largest drug maker Sun Pharmaceutical on Thursday posted a decline of 19 per cent year-on-year (Y-o-Y) for its consolidated net profit for the fourth quarter of the financial year 2025 (Q4FY25) at Rs 2,149.8 crore. Photograph: Francis Mascarenhas/Reuters Meanwhile,